1,1,4,4,6-Pentamethyl-1,2,3,4-tetrahydronaphthalene, 97.0%, 100g

Methyl 4,5-dibromo-1-methyl-1H-pyrrole-2-carboxylate, 98%, 5g

2-((Hydroxymethyl)amino)ethan-1-ol, 98+%, 5g

1,3-Benzodioxole-5-carbonyl chloride, 95.0%, 1g

GC capillary column ROTI®Cap-1, 60 m, 0.32 mm, 0.25 µm, 1 Piece(s)

(5-amino-1-phenyl-1H-pyrazol-4-yl)(1H-indol-3-yl)methanone, 95.0%, 500mg

N-(4-bromobenzyl)ethanamine hydrochloride, 95.0%, 1g

(S)-2-(2-Bromophenyl)-4-(tert-butyl)-4,5-dihydrooxazole, 95.0%, 1g

3-Bromo-2-methylpropanoic acid, 95.0%, 100g

4-Iodo-3,5-dimethylisoxazole, 97.0%, 1g

5,6,7,8-Tetrahydroquinoline, 95.0%, 5g

Methyl 1H-pyrrolo[3,2-b]pyridine-3-carboxylate, 95.0%, 100mg

Nomega-(2-Acetamido-2-deoxy-beta-D-glucopyranosyl)-Nalpha-(tert-butoxycarbonyl)-L-asparagine>96.0%(HPLC)100mg